The role of TLR9 in the development of the autoimmune disease systemic lupus erythematosus is controversial. In different mouse models of the disease, loss of TLR9 abolishes the generation of anti-nucleosome IgG autoantibodies but at the same time exacerbates lupus disease. However, the TLR9-dependent tolerance mechanism is unknown. In this study, we show that loss of TLR9 is associated with low peritoneal B-1b cell numbers and low levels of protective self-reactive IgM serum autoantibodies in lupus-prone FcgRIIB-deficient mice leading to the uncontrolled accumulation of proinflammatory CD4 + cells and exacerbated autoimmunity.
TLR7 signaling was not able to compensate for the loss of TLR9 signaling in peritoneal B-1b cells to induce IgM Abs. Transfer of TLR9-expressing peritoneal B-1b cells from FcgRIIB-deficient mice or of recombinant monoclonal self-reactive IgM Abs was sufficient to reduce the frequency of proinflammatory Th17 cells and lupus disease in FcgRIIB/TLR9 double-deficient mice. Taken together, these data provide evidence for a TLR9-dependent tolerance mechanism of peritoneal B-1b cells generating protective self-reactive IgM in lupus-prone mice to control Th17 cell development and severe autoimmunity. The Journal of Immunology, 2011, 187: 2953-2965.
S ystemic lupus erythematosus (SLE)
is an autoimmune disease characterized by the generation of IgM and IgG autoantibodies against various nuclear Ags such as DNA, nucleosomes, and ribonuclear proteins. However, IgG autoantibodies are positively correlated and IgM autoantibodies are negatively correlated with SLE symptoms (1) (2) (3) (4) . In particular, the IgG/ IgM ratio of self-reactive Abs can be used as prognostic marker for lupus nephritis during the course of the disease (3) . Transfer of anti-dsDNA IgM Abs has further been shown to inhibit the development of nephritis in a murine model of SLE (5) . These studies suggest that self-reactive IgM plays a key role in protecting against severe autoimmunity.
TLR7 and TLR9 stimulation and MyD88 signaling induced by RNA-and DNA-associated self-antigens, respectively, have been shown to play a major role in the activation of dendritic cells and self-reactive B cells (6) (7) (8) (9) . Accordingly, the TLR pathway is known to play an important role in the development of IgG autoantibodies and disease in lupus-prone mice (10) (11) (12) (13) (14) (15) (16) (17) . Although various TLR9-deficient lupus-prone mouse models do not develop anti-nucleosome IgG serum autoantibodies, they do show exacerbated disease progression, indicating that TLR9 also plays a role in self-tolerance (11, 15, (17) (18) (19) (20) (21) . However, the tolerogenic function of TLR9 and the influence of TLR9 on the IgG/IgM ratio of self-reactive Abs in lupus-prone mice are unknown.
In this study, we used C57BL/6 mice deficient for the IgG inhibitory receptor FcgRIIB (FcgRIIB 2/2 ) as a spontaneous model of SLE (12, 22) to determine the influence of TLR9 signaling on the onset of lupus nephritis. Lupus disease was exacerbated in TLR9-deficient FcgRIIB 2/2 (FcgRIIB 2/2 TLR9 2/2 ) mice, with increased numbers of proinflammatory Th1 and Th17 cells and high levels of inflammatory IgG2c (IgG2a haplotype b) and IgG2b serum autoantibodies compared with those in FcgRIIB 2/2 mice.
Loss of TLR9 was associated with low peritoneal B-1b cell numbers and low levels of self-reactive IgM serum autoantibodies in lupus-prone mice. Transfer of TLR9-sufficient peritoneal B-1b cells from FcgRIIB-deficient mice or monoclonal self-reactive IgM Abs into FcgRIIB 2/2 TLR9 2/2 mice inhibited the accumulation of proinflammatory Th17 cells. In summary, our data show a TLR9-dependent tolerance mechanism of peritoneal B-1b cells generating protective self-reactive IgM in lupus-prone mice to control the development of proinflammatory Th17 cells and severe autoimmunity.
Materials and Methods
Mice C57BL/6 mice were purchased from Charles River Laboratories. FcgRIIB
and FcgRIIB 2/2 MyD88 2/2 mice have been described previously (12, 22 
TLR9
2/2 IL-17RA 2/2 tripledeficient mice. All mice were on a C57BL/6 background. Mice were bred and maintained in accordance with institutional guidelines. Female mice were analyzed exclusively. Genotypes were determined by PCR on tail DNA or by FACS (12, 24) .
Bone marrow transfer
Recipient 8-to 12-wk-old FcgRIIB 2/2 female mice were lethally irradiated with 7.5 Gy. Bone marrow (BM) was extracted from donor mice, and T cells were depleted by negative selection using anti-Thy1.2 (clone 30-H12) magnetic microbeads and a MACS magnetic column (Miltenyi Biotec). BM cells (5 3 10 6 ) were transferred into the irradiated recipients. Mixed BM chimeric mice were produced as described previously (27) . Briefly, 4 
MyD88
2/2 mice were transferred into the irradiated recipients. Reconstituted mice were treated with antibiotics and analgesics in the drinking water for 2 wk.
Transfer of peritoneal cells
Peritoneal cells were obtained by injecting 3 ml PBS/BSA into the peritoneal cavities of 3-mo-old donor mice and washing with PBS/BSA. Then, 0.5 3 10 7 to 1. 
Anti-CD21 injection
Anti-CD21 (clone 7G6) Ab (4 mg) was injected i.p. into mice at days 0 and 8 (28) .
TLR stimulation in vivo
Eight-week-old FcgRIIB 2/2 or FcgRIIB 2/2 MyD88 2/2 mice were injected i.p. with either 50 mg CpG ODN 1826 (Invivogen) or 25 mg imiquimod (Invivogen) or a combination of both. Mice were killed and analyzed at day 7.
Cell culture
Spontaneous secretion of IgM from 2 3 10 7 total splenocytes or total peritoneal cells or of IL-10 or IL-6 from 2 3 10 7 total splenocytes or 5 3 10 6 total peritoneal cells was induced in 24-or 48-well plates with 800 or 500 ml RPMI 1640 (Life Technologies) containing 10% FCS, 1% penicillin/streptomycin, and 50 mM 2-mercaptoethanol, respectively. Supernatants were collected after 48 h, and secreted self-reactive IgM, IL-10, or IL-6 levels were determined by ELISA. 
MyD88
2/2 females were incubated in 96-well plates with 200 ml RPMI 1640 (Life Technologies) containing 10% FCS, 1% penicillin/streptomycin, 50 mM 2-mercaptoethanol, and 5 mg/ml CpG ODN 1826 or 5 mg/ml imiquimod or both together as indicated. After 96 h, supernatants were collected and secreted total IgM or ANA IgM, IgG, or IgA was determined by ELISA, and cells were analyzed by FACS.
Cloning of monoclonal human/mouse chimeric and mouse IgM Abs
The human IgG1 and k constant regions in the H and L chain expression vectors of the monoclonal self-reactive and polyreactive human Ab ED38 and the control human Ab mgo53 (29) and the self-reactive and polyreactive murine Ab 1RIIgc7 (30) were exchanged for the murine IgM H chain (SalI-BsiWI) and murine k L chain (BsiWI-HindIII) constant regions, which were amplified by PCR from a generated C57BL/6 splenic cDNA, respectively (murine IgM H chain C region, forward primer 59-CCTCGCGTCGACGTCCTTCCCAAATGTCTTCCCCCT-39, reverse primer 59-TTATTCGGCGTACGCGTCAATAGCAGGTGCCGCCTGTG-39; murine k L chain C region, forward primer 59-CCTCGCCGTACG-GATGCTGCACCAACTGTATCCATC-39, reverse primer 59-TTATTCG-GAAGCTTTCAACACTCATTCCTGTTGAAG-39). The leader sequences of the original expression vectors were used (29) .
Production and purification of monoclonal IgM Abs
HEK293T cells were cultured and transfected as previously described (29) . The IgM Abs in the supernatant were purified with an anti-IgM Sepharose column (in-house preparation with anti-mouse IgM [clone M41] and CnBr-activated Sepharose 4B [GE-Healthcare]). The monoclonal IgM Abs were eluted with 0.1 M glycine, pH 2.7, collected in 1:10 volume 1 M TrisHCl pH 9 and dialyzed against PBS. The concentration of the murine IgM Abs was determined by bicinchoninic acid assay (Pierce) and verified by IgM ELISA. Ab integrity was analyzed by SDS gel analysis, and selfreactivity was verified by ELISA.
Determination of proteinuria
Proteinuria was measured using Multistix 10 Visual (Bayer) strips and scored as follows: 0, negative; 1, #75 mg/dl; 2, #125 mg/dl; 3, .125 mg/dl.
ELISA
ELISA was performed as previously described (12, 29) . ELISA plates for the detection of anti-nucleosome and anti-nuclear (ANA-Detect) Abs were purchased from Orgentec. For anti-IgG rheumatoid factor (RF) ELISA, 5 mg/ml protein G-Sepharose-purified anti-human CD4 murine IgG1 (hybridoma clone TT1) was coated on the plates. For anti-human/mouse chimeric IgM ELISA, purified ED38 or control (mgo53) IgM were coated on the plates. For anti-insulin, anti-dsDNA, anti-ssDNA, and anti-LPS ELISA, 5 mg/ml of the corresponding Ag was coated on the plates. Plates were blocked with 150 ml PBS, 3% BSA, 1 mM EDTA, and 0.1% gelatin and subsequently incubated with 1:100 diluted serum or different concentrations of purified Ab in PBS. Ig subclasses and isotypes were detected with 100 ml HRP-coupled polyclonal goat anti-mouse IgM, IgA, IgG, IgG2c (IgG2a haplotype b), or IgG2b specific secondary Abs (Bethyl Laboratories). Total IgM or IgG Abs were measured using ELISA plates coated with 100 ml 5 mg/ml polyclonal goat anti-mouse IgM or IgG in 0.05 M carbonate/bicarbonate buffer pH 9.6 and developed with HRPcoupled anti-mouse IgM or IgG. Reference samples (Bethyl Laboratories) were used to calculate the IgM concentration of purified IgM Abs. The mouse IL-10 and IL-6 ELISA Kits were purchased from BD Biosciences Pharmingen.
Flow cytometric analysis and cell sorting
The following fluorochrome-coupled anti-mouse Abs were used: anti-CD138 (clone N418), anti-IL-17 (TC11-18H10), anti-CD5 (53-7.3), anti-CD4 (RM4-5) (from BD), anti-CXCR3 (220803) (from R&D Systems), anti-CD43 (BioR2/60) (from eBioscience), anti-B220 (RA3-6B2), anti-CD4 (GK1. 5 
Immunofluorescence assays
Immunofluorescence analyses of kidney sections were performed as previously described (12) . Slides were incubated with the following fluorochrome-coupled anti-mouse Abs: anti-IL-17 (TC11-18H10), anti-CD4 (GK1.5), anti-Mac-1 (M1/70.15.11), anti-F4/80, and anti-IgG2c (polyclonal goat Abs; Bethyl).
Semiquantitative PCR
Mixed BM chimeric mice were killed 6 mo after BM transfer, and splenic B220 + B cells and B220 2 non-B cells were sorted using a FACSAria (Becton Dickinson) cell sorter. Genomic DNA was prepared and analyzed by semiquantitative PCR (28 cycles) for TLR9 knockout and wild-type genomic DNA with a BioRad C1000 Thermal Cycler (TLR9 forward primer 59-CATGGCCTGGTGGACTGCAA-39; TLR9 wild-type reverse primer 59-TGAAGAGAACGCGCAGG-39; TLR9 knockout reverse primer 59-ATCGCCTTCTATCGCCTTCTTGACGAG-39). The intensity of the bands was measured using ImageJ 1.44p (National Institutes of Health).
Statistical analysis
Statistical analyses were performed using the Student t test or the log-rank test for survival curves: *p , 0.05, **p , 0.01, ***p , 0.001. Correlations were calculated with the Pearson correlation coefficient.
Results

Exacerbated lupus disease in FcgRIIB
2/2 TLR9 2/2 mice is associated with increased levels of proinflammatory Th1 and Th17 cells and T cell-dependent IgG2c and IgG2b serum autoantibodies
In our mouse facility, ∼20% of lupus-prone FcgRIIB 2/2 mice developed nephritis and died of disease symptoms by the age of 9 mo (Fig. 1A, Supplemental Fig. 1 ). Mortality was significantly increased to 80% in FcgRIIB 2/2 mice lacking TLR9 (FcgRIIB
), whereas a lack of MyD88 protected FcgRIIB 2/2 mice from developing lupus disease (Fig. 1A) (12) . Loss of TLR9 was associated with low levels of anti-nucleosome (11, 17, 20) (Fig. 1C, Supplemental Fig. 1 ). In addition, frequencies of 
Loss of TLR9 in BM-derived B cells promotes development of proinflammatory CD4 + T cells and lupus disease in FcgRIIB
TLR9
2/2 (chim RT) mice ( Fig. 2A) . The irradiation dose was thereby sufficient to inhibit host recovery of the immune system (Supplemental Fig. 4 ). Chim RT mice resembled FcgRIIB
2/2 mice in that they showed high numbers of activated proinflammatory CD4 + T cells, high levels of IgG2c ANA IgG2c and IgG2b in the absence of anti-nucleosome serum autoantibodies, and increased nephritis-induced mortality in comparison with those of chim R mice ( Fig. 2B-D 
CD4
+ Th cell numbers and ANA IgG2c as well as nephritis-induced mortality were enhanced in comparison with those of control chim RJ+R mice ( Fig. 3B-D ). By contrast, chim RJ+RM mice with MyD88-deficient B cells lacked inflammatory T cell responses and IgG2c and IgG2b serum autoantibodies and showed no mortality ( Fig. 3B-D) .
We therefore conclude that B cell-intrinsic MyD88 signaling is important for the induction of inflammatory immune responses. However, B cell-intrinsic TLR9 signaling is not only crucial for the generation of anti-nucleosome IgG2c and IgG2b autoantibodies but also for controlling the accumulation of proinflammatory T cells and inflammatory autoimmune reactions associated with end-organ damage and lupus disease.
B cell-intrinsic TLR9 stimulation regulates self-reactive IgM levels TLR-dependent tolerance mechanisms in B cells have been associated with production of the anti-inflammatory cytokine IL-10, protecting from autoimmunity (31) . However, IL-10 production by total cultured splenocytes or by peritoneal cells of TLR9-deficient FcgRIIB 2/2 mice was not reduced compared with that by TLR9-sufficient FcgRIIB 2/2 mice (Fig. 4A ).
Self-reactive IgM autoantibodies have also been described to play a role in protecting against the development of lupus disease symptoms in mice and humans (3) (4) (5) 32) . To establish whether exacerbated lupus disease in TLR9-deficient FcgRIIB 2/2 mice is associated with changes in self-reactive IgM levels, we measured self-reactive serum IgM Ab levels by ELISA (Fig. 4B) . Five-to six-month-old FcgRIIB 2/2 mice showed increased levels of selfreactive ANA and anti-IgG RF and total serum IgM levels in comparison with those of age-matched C57BL/6 wild-type control (27) . Using this approach, we ensured that the function of hematopoietic non-B cells was minimally impaired, whereas TLR9 or MyD88 function in B cells was abolished (27) . http://www.jimmunol.org/ mice (Fig. 4B) . Surprisingly, self-reactive and total serum IgM Ab levels were significantly reduced in 5-to 6-mo-old MyD88-and TLR9-deficient FcgRIIB 2/2 mice and were thus comparable with the levels measured in age-matched C57BL/6 wild-type controls (Fig. 4B ). These differences in IgM levels were already seen in young 3-mo-old animals ( Fig. 4C and data not shown). Selfreactive ANA or anti-IgG RF IgM levels were also reduced in chim RT mice and chim RJ+RT and chim RJ+RM mice with TLR9-or MyD88-deficient B cells, respectively, compared with those in control chim R and chim RJ+R mice (Fig. 4D, 4E ). We therefore conclude that the development of self-reactive IgM serum Abs in autoimmune FcgRIIB 2/2 mice depends on B cellintrinsic MyD88-mediated TLR9 signaling. Fig. 8 ), suggesting a role of TLR9 in the maintenance of peritoneal B-1b cell numbers. Indeed, peritoneal B-1b cells but not B-1a cells were already reduced in TLR9-deficient C57BL/6 mice compared with those in wild-type C57BL/6 mice ( Fig. 5B-D (Fig. 5I) . (Fig. 6A, 6B , Supplemental Fig. 9 , and data not shown) (37). As described recently, TLR7 signaling counteracts TLR9 signaling in B cells (39) . Indeed, the activation of TLR9 and TLR7 together reduced B cell proliferation and IgM production. TLR7 signaling alone induced neither B cell proliferation nor IgM production ( Fig. 6A-D) . Any induction of self-reactive IgG and IgA Abs was below the detection limit (Supplemental Fig. 9 ). It is worth mentioning that proliferation of B-1a cells was reduced compared with that of B-1b cells when total peritoneal B-1 cells were sorted and stimulated in vitro with CpG (Fig. 6C, 6D ).
Comparable results were seen after in vivo i.p. stimulation of FcgRIIB 2/2 or FcgRIIB 2/2 MyD88 2/2 mice with CpG, imiquimod, or a combination of both ( Fig. 6E-H, Supplemental Fig. 10 ). CpG highly induced MyD88-dependent peritoneal B-1b and B-2 cell proliferation and IgM but hardly IgG or IgA levels. However, proliferation of peritoneal B-1a cells was highly reduced. Thus, MyD88-dependent TLR9 but not TLR7 signaling induces peritoneal B-1b cell proliferation and IgM production, TLR9 signaling does not induce B-1a cell proliferation in vivo, and B-2 cell proliferation by TLR9 stimulation is accompanied by only low IgM production. (Fig. 7A, 7B) . Instead, repeated transfer of peritoneal cells from FcgRIIB (Fig. 7D, 7E) . Accordingly, transfer of peritoneal B-1b cells from FcgRIIB 2/2 mice temporarily tended to enhance self-reactive IgM levels and reduced Th17 cell frequencies (Fig. 7F) (Fig. 8B, 8C ).
Transfer of peritoneal B-1b cells from FcgRIIB
IgG2c and IgG2b serum autoantibody levels are higher in 5-to 6-mo-old FcgRIIB 2/2 TLR9 2/2 mice, which develop proteinuria, compared with those in mice that do not develop proteinuria until the age of 8 mo (Fig. 8D) . Accordingly, ED38 IgM-treated mice tend to have lower self-reactive IgG serum Ab levels compared with those of control IgM (mgo53)-treated mice (Fig. 8D) . Furthermore, at the age of 9 mo, ED38 IgM-treated mice showed IgG2c immune complexes but no macrophage infiltration in the kidney in comparison with untreated FcgRIIB 2/2 TLR9 2/2 mice with proteinuria (Supplemental Fig. 12) . Notably, one i.p. transfer (200 mg) of the monoclonal self-reactive and polyreactive ED38 IgM Ab or of a self-reactive and polyreactive mouse IgM Ab (1RIIgc7) but not of the control IgM Ab (mgo53) into 5-to 6-moold FcgRIIB 2/2 TLR9 2/2 mice was sufficient to reduce the frequency of proinflammatory Th17 cells already after 9 d (Fig. 8E) . One i.p. transfer of the monoclonal self-reactive and polyreactive mouse IgM Ab (1RIIgc7; 200 mg) into 5-to 6-mo-old FcgRIIB 2/2 mice had no effect after 9 d (Fig. 8F) . analyzed by CD5 expression at day 7. that B-1b cells have a tolerogenic function, but underlying mechanisms have been unknown (44, 45) . Our findings now show that loss of MyD88-dependent TLR9 signaling is associated with reduced peritoneal B-1b cell numbers and reduced protective self-reactive IgM serum levels in lupus-prone FcgRIIB 2/2 mice leading to the uncontrolled accumulation of proinflammatory CD4 + T cells and severe autoimmunity. TLR9-deficient but not TLR9-sufficient FcgRIIB 2/2 mice showed a significant reduction of peritoneal B-1b cells compared with C57BL/6 wild-type mice even at young age suggesting that TLR9 plays a key role in regulating peritoneal B-1b cells. This observation was confirmed by the fact that already TLR9 2/2 mice showed reduced B-1b cell numbers and that B-1b cells, but hardly B-1a cells, are highly responsive to CpG in vivo. Thus, TLR9 seems to be essential for peritoneal B-1b cell number maintenance. In contrast to B-1a cells, secretion of IgM Abs by B-1b cells requires Ag-mediated activation (46) (47) (48) (49) (50) (51) (52) . Loss of FcgRIIBdependent negative feedback mechanisms in self-reactive peritoneal B-1b cells may promote their activation by TLR9 ligand http://www.jimmunol.org/ containing Ags via the BCR and TLR9 and MyD88 costimulation (7, 34, 48, 53) and thus the secretion of self-reactive IgM serum Abs (54) . Thus, two mechanisms might be responsible for the reduced levels of self-reactive IgM serum autoantibodies in TLR9-and MyD88-deficient 
